4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000061
Options or other derivatives
- Chief Scientific Officer acquired 4,276.45 shares (option exercise)
- Chief Scientific Officer acquired 142,547 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Jewell Christopher M · Chief Scientific Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-08 | Exercise or conversion : show line 1 in the form Stock Option (Right to Buy) | −4,276.45 | 0 | D |
| 2024-04-08 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | +142,547 | 142,547 | D |
Loading xslF345X05/wk-form4_1712799327.xml…